Center for Breakthrough Medicines Plans for an Even Larger Dive Into Cell Therapy Manufacturing
In an email to Endpoints News, John Lee, VP and head of cell therapy at CBM, said its new one million square foot cell therapy expansion will include 90,000 square feet of GMP manufacturing space as well as offices and warehouse space. Lee also said that the facility’s cost will be in the hundreds of millions, but no exact figure was given. Once completed, this will be one of the largest producers of cell therapy in the world.
“We have leveraged knowledge gained from our current build and forward engineered the facility to enable modularity and to increase efficiency to better serve clients (and patients). Modular suite design across approximately 90,000 square feet of Grade-B GMP space will enable agility and flexibility to accommodate an array of processes,” Lee said in an email.